四逆左金汤治疗胃食管反流病的疗效与潜在机制
但GRADE证据质量低,复发与安全性结果经试验序贯分析仍不确定。网络药理学提示其可能通过炎症、激素调节等相关靶点和通路发挥作用。
要点
- 四逆左金汤联合传统胃药治疗胃食管反流病疗效优于单用传统胃药。
- 可改善烧心、胸骨后疼痛、反酸和反食症状,并降低复发率和不良反应。
- 证据质量低,长期疗效与具体临床机制尚不明确,需更多高质量研究验证。
核心结论
- 四逆左金汤可能对胃食管反流病治疗有用,但长期效果和具体临床机制尚不明确。
- 因证据质量较差,未来需更多样本和高质量临床研究验证。
研究设计与样本
- 采用RevMan 5.3进行Meta分析和偏倚风险评估,Stata 14.0进行敏感性分析,GRADE profiler 3.6评价证据水平,试验序贯分析控制随机误差,并应用网络药理学初步研究作用机制。
主要发现
- 四逆左金汤联合传统胃药组疗效优于传统胃药组(RR=1.16,95% CI [1.04, 1.29],P=0.009)。
- 四逆左金汤试验组在改善烧心、胸骨后疼痛、反酸和反食症状方面显著优于传统胃药对照组(P<0.0001)。
- 四逆左金汤联合传统胃药可显著降低总症状评分(P<0.00001),且四逆左金汤治疗的复发率和不良反应显著降低(P<0.05)。
- 试验序贯分析显示有效率Meta分析结果可能可靠,但复发和安全性结果仍不确定;GRADE评价证据质量低。
- 网络药理学提示四逆左金汤可能通过作用于炎症、激素调节等相关靶点和通路治疗胃食管反流病。
关键数值与推荐
- Meta分析显示四逆左金汤联合传统胃药组疗效优于传统胃药组,RR=1.16,95% CI [1.04, 1.29],P=0.009。
- 症状改善(烧心、胸骨后疼痛、反酸、反食)比较的P<0.0001;总症状评分降低的P<0.00001;复发率和不良反应降低的P<0.05。
- GRADE方法评价证据质量低。
临床怎么用
- 在临床中可考虑将四逆左金汤联合传统胃药用于胃食管反流病患者以改善疗效和症状。
- 需注意现有证据质量低,长期疗效和安全性尚不确定,应结合患者具体情况谨慎决策。
局限性
- 纳入研究的方法学质量较差,GRADE评价证据质量低。
- 四逆左金汤的长期效果和具体临床机制尚不明确。
- 试验序贯分析提示复发和安全性结果仍不确定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Based on 122 cases reported in China, data mining indicated that Sini Powder (SNP) and the Zuojin Pill (ZJP) are both widely used as the basic recipe for treating Gastroesophageal Reflux Disease (GERD). OBJECTIVES: To evaluate the intervention effects of Sini Zuojin Decoction (SNZJD) in patients with GERD. METHODS: A comprehensive collection of randomized controlled trials (RCTs) using SNZJD in patients with GERD that were published in domestic and foreign journals was made by computer retrieval. RevMan 5.3 software was used for meta-analysis and bias risk assessment, Stata 14.0 software was used for sensitivity analysis, GRADE profiler 3.6 was used to evaluate the level of evidence, and trial sequential analysis (TSA), employed to control for random errors, was performed to assess the main outcomes. Network pharmacology analysis was applied to preliminarily study the mechanisms of action of SNZJD on GERD. RESULTS: Thirteen articles were eventually included, covering a total of 966 patients. Meta-analysis indicated that: ① the SNZJD plus traditional stomach medicines (SPTSM) group was more effective than the traditional stomach medicines (TSM) group (RR = 1.16, 95% CI [1.04, 1.29], P = 0.009); ② the experimental group with SNZJD was significantly better than TSM controls in improving heartburn, substernal chest pain, acid regurgitation, and food regurgitation symptoms (P < 0.0001); ③ SPTSM could significantly decrease total symptom scores with substantial effectiveness (P < 0.00001). The recurrence rate and adverse effects of SNZJD treatment were significantly reduced (P < 0.05). TSA showed that the effective rate of meta-analysis might be reliable, but the recurrence and safety results were still uncertain. According to the evaluation by the GRADE method, the quality of evidence was low. Besides, SNZJD might treat GERD by acting on related targets and pathways such as inflammation, hormone regulation, and so on. CONCLUSIONS: SNZJD might be useful in the treatment of GERD, but its long-term effects and specific clinical mechanisms are unclear. Due to the poor quality of the evidence, more samples and high-quality clinical studies should be tested and verified in the future.
引用
- Li S, Huang M, Wu G, et al. Efficacy of Chinese Herbal Formula Sini Zuojin Decoction in Treating Gastroesophageal Reflux Disease: Clinical Evidence and Potential Mechanisms. Front Pharmacol. 2020. PMID: 32174826. doi:10.3389/fphar.2020.00076
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。